7.91
前日終値:
$7.17
開ける:
$7.13
24時間の取引高:
1.49M
Relative Volume:
1.34
時価総額:
$639.09M
収益:
-
当期純損益:
$-106.81M
株価収益率:
-2.3885
EPS:
-3.3117
ネットキャッシュフロー:
$-8.40M
1週間 パフォーマンス:
+27.58%
1か月 パフォーマンス:
-12.50%
6か月 パフォーマンス:
-34.57%
1年 パフォーマンス:
-54.49%
Immunome Inc Stock (IMNM) Company Profile
IMNM を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IMNM
Immunome Inc
|
7.91 | 639.09M | 0 | -106.81M | -8.40M | -3.3117 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-02 | 開始されました | Lake Street | Buy |
2024-11-08 | 開始されました | Stephens | Overweight |
2024-05-31 | 開始されました | Piper Sandler | Overweight |
2024-04-30 | 開始されました | JP Morgan | Overweight |
2024-04-15 | 開始されました | Guggenheim | Buy |
2024-01-29 | 開始されました | Leerink Partners | Outperform |
2023-12-19 | 開始されました | Wedbush | Outperform |
2021-10-29 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Immunome Inc (IMNM) 最新ニュース
Immunome: Transformed Pipeline Offers Multiple Catalysts (NASDAQ:IMNM) - Seeking Alpha
JPMorgan Chase & Co. Acquires 624,045 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
How To Trade (IMNM) - news.stocktradersdaily.com
Wellington Management Group LLP Raises Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Vanguard Group Inc. Sells 128,130 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome Announces Management Changes - marketscreener.com
KLP Kapitalforvaltning AS Invests $75,000 in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Corebridge Financial Inc. Sells 1,929 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Commonwealth Equity Services LLC Buys Shares of 19,017 Immunome, Inc. (NASDAQ:IMNM) - Defense World
Raymond James Financial Inc. Acquires Shares of 25,817 Immunome, Inc. (NASDAQ:IMNM) - Defense World
Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last? - Yahoo Finance
Brokerages Set Immunome, Inc. (NASDAQ:IMNM) PT at $25.14 - Defense World
Immunome stock hits 52-week low at $5.5 amid market challenges - Investing.com
Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference - BioSpace
Immunome's Latest Cancer Therapy Progress: Key Investor Presentation Coming to Needham Conference - Stock Titan
Lake Street Capital Begins Coverage on Immunome (NASDAQ:IMNM) - Defense World
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe
Teacher Retirement System of Texas Purchases New Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Clay Siegall Bought 20% More Shares In Immunome - simplywall.st
Corient Private Wealth LLC Sells 12,149 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome stock hits 52-week low at $6.94 amid market challenges - Investing.com Australia
Immunome stock hits 52-week low at $6.94 amid market challenges By Investing.com - Investing.com South Africa
Immunome (NASDAQ:IMNM) Stock Price Up 4.4% After Insider Buying Activity - Defense World
Immunome (IMNM) Stock Climbs as Executives Increase Holdings - GuruFocus
Immunome director Jean Jacques Bienaime acquires $60,684 in stock - Investing.com
Immunome director Jean Jacques Bienaime acquires $60,684 in stock By Investing.com - Investing.com South Africa
Immunome CEO Clay Siegall buys $999k in stock By Investing.com - Investing.com Canada
Immunome CEO Clay Siegall buys $999k in stock - Investing.com India
Immunome stock rises after insider purchase (IMNM:NASDAQ) - Seeking Alpha
Immunome stock rises after insider purchase - MSN
Immunome director Jean Jacques Bienaime purchases $57,470 in stock By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Increases Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome CTO Philip Tsai purchases $103,566 in stock By Investing.com - Investing.com Canada
Immunome director Jean Jacques Bienaime purchases $57,470 in stock - Investing.com
Immunome CTO Philip Tsai purchases $103,566 in stock - Investing.com
Bank of New York Mellon Corp Has $1.31 Million Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Wedbush Has Positive Estimate for Immunome Q1 Earnings - Defense World
Immunome (NASDAQ:IMNM) Receives Outperform Rating from Wedbush - MarketBeat
Immunome’s (IMNM) “Outperform” Rating Reiterated at Wedbush - Defense World
Guggenheim Has Lowered Expectations for Immunome (NASDAQ:IMNM) Stock Price - Defense World
Stephens Reiterates Overweight Rating for Immunome (NASDAQ:IMNM) - Defense World
Trading (IMNM) With Integrated Risk Controls - news.stocktradersdaily.com
Immunome Full Year 2024 Earnings: Misses Expectations - Yahoo
Immunome’s 2024 Financial Results and Pipeline Progress - TipRanks
Immunome stock target cut to $25 by Guggenheim - Investing.com Australia
Immunome Inc (IMNM) 財務データ
収益
当期純利益
現金流量
EPS
Immunome Inc (IMNM) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
BIENAIME JEAN JACQUES | Director |
Mar 25 '25 |
Buy |
7.78 |
7,800 |
60,684 |
31,415 |
SIEGALL CLAY B | President and CEO |
Mar 26 '25 |
Buy |
7.29 |
137,100 |
999,459 |
806,736 |
BIENAIME JEAN JACQUES | Director |
Mar 24 '25 |
Buy |
8.21 |
7,000 |
57,470 |
23,615 |
Tsai Philip | Chief Technology Officer |
Mar 24 '25 |
Buy |
8.42 |
12,300 |
103,566 |
33,300 |
SIEGALL CLAY B | President and CEO |
Jan 31 '25 |
Buy |
7.75 |
150,000 |
1,162,500 |
669,636 |
SIEGALL CLAY B | President and CEO |
Nov 21 '24 |
Buy |
9.54 |
66,057 |
630,263 |
485,693 |
SIEGALL CLAY B | President and CEO |
Nov 22 '24 |
Buy |
9.78 |
33,943 |
331,918 |
519,636 |
Lechleider Robert | Chief Medical Officer |
Nov 21 '24 |
Buy |
9.48 |
15,805 |
149,800 |
15,805 |
Tsai Philip | Chief Technology Officer |
Nov 21 '24 |
Buy |
9.43 |
21,000 |
198,030 |
21,000 |
Rosett Max | Chief Financial Officer |
Sep 19 '24 |
Option Exercise |
1.05 |
42,000 |
44,100 |
61,856 |
大文字化:
|
ボリューム (24 時間):